Y V Zhylchuk

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
UNLABELLED The androgen-suppressive therapy (AST) in patients with prostate cancer (PC) may dramatically affect the bone mineral density (BMD), which puts patients at risk of severe adverse effects, such as weight-bearing bone fractures. AIM To study the effect of AST on BMD in patients with non-metastatic hormone-sensitive PC treated with intermittent(More)
  • 1